Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Parham

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Physics in Medicine and Biology|May 8, 2009
Characterization of diffraction-enhanced imaging contrast in breast cancerT Kao, D Connor, F A Dilmanian, et al.
Biochemical Pharmacology|December 1, 1980
Analog specific aberrancies in antifolate inhibition of L1210 cell dihydrofolate reductaseF M Sirotnak, P L Chello, D M Moccio, et al.
Cancer Research|May 1, 1973
Correlations between oncogenic and chemical properties of several derivatives of 3-hydroxyxanthine and 3-hydroxyguanineG B Brown, M N Teller, I Smullyan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptorY Liu, R de Waal Malefyt, F Briere, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Physics in Medicine and Biology|May 8, 2009
Characterization of diffraction-enhanced imaging contrast in breast cancerT Kao, D Connor, F A Dilmanian, et al.
Biochemical Pharmacology|December 1, 1980
Analog specific aberrancies in antifolate inhibition of L1210 cell dihydrofolate reductaseF M Sirotnak, P L Chello, D M Moccio, et al.
Cancer Research|May 1, 1973
Correlations between oncogenic and chemical properties of several derivatives of 3-hydroxyxanthine and 3-hydroxyguanineG B Brown, M N Teller, I Smullyan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptorY Liu, R de Waal Malefyt, F Briere, et al.
Pageof 4